Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

EXJADE

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of EXJADE in Canada?

A shortage of EXJADE 250MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 31, 2026), but it has not started yet.

Why is EXJADE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will EXJADE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Affected strength250MG
Last updated2026-08-31

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

APO-DEFERASIROX

APOTEX INC

250MG · DIN 02461552

Same strengthSame dosage formSame routeNo current shortage

Other Products

EXJADE

NOVARTIS PHARMACEUTICALS CANADA INC

125MG · DIN 02287420

Different strengthSame dosage formSame routeNo current shortage

ALEMBIC-DEFERASIROX (TYPE J)

ALEMBIC PHARMACEUTICALS LIMITED

360MG · DIN 02564939

Different strengthDifferent dosage formSame routeNo current shortage

TARO-DEFERASIROX (TYPE J)

TARO PHARMACEUTICALS INC

360MG · DIN 02507331

Different strengthDifferent dosage formSame routeNo current shortage

JAMP DEFERASIROX (TYPE J)

JAMP PHARMA CORPORATION

360MG · DIN 02549859

Different strengthDifferent dosage formSame routeNo current shortage

APO-DEFERASIROX (TYPE J)

APOTEX INC

180MG · DIN 02485273

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02287439

Strength

250MG

Dosage Form

TABLET FOR SUSPENSION

Route

ORAL

Active Ingredient

DEFERASIROX

Tier

Unrated

Last Updated

2026-08-31

Reason for Shortage

Disruption of the manufacture of the drug.